How To Differentiate Driver Mutations From Common Mutations And Snps In Cancer Rna-Seq Data
Entering edit mode
8.6 years ago
monukmr98 ▴ 80

Hi all,

I am working on RNA-seq data ( our own experimental data) for some cancer types of human. I want to know whether the genes found/mapped in the raw data have mutations significantly different from the normal mutations found in the cells. (i.e. distinguish somatic mutations from germline mutations). Also I want to negate significant driver mutations from the SNPs. So what packages are available for this task (what is the protocol exactly) ?. Also, which databases I have to compare my data with to exclude the obvious mutations/variations in my patient samples?




mutation cancer snp • 3.4k views
Entering edit mode
8.6 years ago

What is typically done is to compare tumor to matched normal to define somatic mutations. However, this will be challenging in RNA-seq data since many genes expressed in the tumor will not be expressed in the normal. Also, variable levels of expression contribute to difficulties in calling variants in RNA-seq. These two issues reduce the ability to successfully call somatic variants from matched tumor/normal RNA-seq.

As for databases to compare with, dbSNP, NHLBI ESP, several personal genomes, Complete Genomics datasets, and several others detailed here:

You'll also want to be aware of the COSMIC database to see if variants have been observed in cancer before.

Tools like annovar, snpEff, SIFT, polyphen2, and others can help to determine the potential impact of individual variants on genes.


Login before adding your answer.

Traffic: 1848 users visited in the last hour
Help About
Access RSS

Use of this site constitutes acceptance of our User Agreement and Privacy Policy.

Powered by the version 2.3.6